Close Menu

NEW YORK — Transplant Genomics said today that its TruGraf Blood Gene Expression kidney transplant test qualifies for Medicare coverage beginning on Nov. 25.

TruGraf is a DNA microarray test that assesses differentially expressed genes in blood to rule out subclinical kidney transplant rejection in patients with stable renal function, providing an alternative to surveillance biopsies. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.